BioSpace News Archive

Twist Bioscience Corporation (Nasdaq: TWST) today launched the Twist Library Preparation Enzymatic Fragmentation Kit 2.0 , a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS).

Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the in-licensing of two new research programs from Scripps Research. One program targets tau, a key driver of dementia disorders

Primary endpoint of non-inferior immunogenicity versus the Phase 3 study adult comparator group was met No cases of COVID-19 observed after two doses of vaccine using the primary case definition, consistent with a vaccine efficacy of 100% Safety and tolerability generally consistent with Phase 3 COVE study in adults; no significant safety concerns identified

Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning (ML), and engineering, today announced the company has initiated investigational new drug (IND)-enabling studies for REC-163964

Quotient Limited, a commercial-stage diagnostics company, announced that financial results for its fiscal fourth quarter and full year ended March 31, 2021 will be released before market open on Tuesday, June 1, 2021.

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoife Brennan , M.B. Ch.B., Synlogic’s President and Chief Executive Officer, and other members of the executive team will present at the following virtual banking and industry conference

ChoiceSpine LLC, a privately held spinal device manufacturer based in Knoxville, TN, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk Ti Cervical Spacer System.

Synaptive Medical, a leader in MRI and surgical robotics, has announced the appointment of Mark Hanrahan as Chief Financial Officer.

NextPhase Medical Devices LLC, a leading provider of electronic manufacturing services (EMS) and single-use disposable devices to leading medical device OEMs, recently announced the acquisition of Proven Process Medical Devices Inc.

Oculogica, a leader in concussion diagnosis and categorization, with the only FDA-cleared technology that aids in the diagnosis of concussion without a pre-injury baseline test requirement, announced today the granting of U.S. Patent No. 11,013,441 by the U.S. Patent and Trademark Office